The humoral immune response defends against pathogens that are free in the blood by using antibodies against pathogen-specific antigens.
- Summarize the humoral immune response
- Antigens are proteins and other macromolecules that bind to a specific antibody and are used by the immune system to recognize pathogens.
- B cells express receptors (BCRs) on their membrane which contain antibodies; these antibodies allow B cells to detect pathogens and release further antibodies to fight the infection.
- Antibodies fight infections in three ways: they mark pathogens for destruction by phagocytic cells in a process known as opsonization, they coat key sites on pathogens necessary for infection, and they induce the complement cascade to occur against antibody-bound pathogens.
- Once the adaptive immune response has encountered an antigen, B cells will divide to produce plasma cells, which rapidly secrete antibodies to that antigen in a process called active immunity.
- antibody: a protein produced by B-lymphocytes that binds to a specific antigen
- opsonize: to make (bacteria or other cells) more susceptible to the action of phagocytes by use of opsonins
- MHC: an acronym for major histocompatibility complex; these extracellular protein receptors display antigens derived from extracellular (class I) or intracellular (class II) proteins and other biomolecules
The humoral immune response fights pathogens that are free in the bodily fluids, or “humours”. It relies on antigens (which are also often free in the humours) to detect these pathogens. An antigen is a biomolecule, such as a protein or sugar, that binds to a specific antibody. An antibody/antigen interaction may stimulate an immune response. Not every biomolecule is antigenic and not all antigens produce an immune response. B cells are the major cell type involved in the humoral immune response. When a foreign antigen (one coming from a pathogen, for example) is detected, B cells in the body that recognize that antigen will begin to produce antibodies as a means of fighting off the foreign invader.
B cell maturation
During maturation, B cells gain antigen receptor molecules, termed B cell receptors (BCRs), which are displayed in large numbers, extracellularly on their membrane. These membrane-bound protein complexes contain antibodies, which enable specific antigen recognition. Each B cell initially produced has only one kind of antibody (antigen receptor), which makes every B cell unique. It is the immense number of B cells in the body, each of which produces a unique antibody, that allows the immune system to detect such a wide variety of pathogenic antigens. B cells containing antibodies that recognize “self” antigens are destroyed before they can mature, preventing the immune system from attacking the host. Once B cells mature in the bone marrow, they migrate to lymph nodes or other lymphatic organs, where they may begin to encounter pathogens.
B cell receptors: B cell receptors, containing antibodies (termed antigen-binding site in the picture) are embedded in the membranes of B cells and bind a variety of antigens through their variable regions.
B cell activation
When a B cell encounters the antigen that binds to its receptor, the antigen molecule is brought into the cell by endocytosis, reappearing on the surface of the cell bound to an MHC class II molecule. When this process is complete, the B cell is sensitized. In most cases, the sensitized B cell must then encounter a specific kind of T cell, called a helper T cell, before it is activated. This activation of the helper T cell occurs when a dendritic cell presents an antigen on its MHC II molecule, allowing the T cell to recognize it and mature.
The helper T cell binds to the antigen-MHC class II complex and is induced to release cytokines that induce the B cell to divide rapidly, making thousands of identical (clonal) cells. These daughter cells become either plasma cells or memory B cells. The memory B cells remain inactive at this point. A later encounter with the antigen, caused by a reinfection by the same bacteria or virus, will result in them dividing into a new population of plasma cells. The plasma cells, on the other hand, produce and secrete large quantities, up to 100 million molecules per hour, of antibody molecules. An antibody, also known as an immunoglobulin (Ig), is a protein that is produced by plasma cells after stimulation by an antigen. Antibodies are the agents of humoral immunity. Antibodies occur in the blood, in gastric and mucus secretions, and in breast milk. Antibodies in these bodily fluids can bind pathogens and mark them for destruction by phagocytes before they are able to infect cells.
These antibodies circulate in the blood stream and lymphatic system, binding with the antigen whenever it is encountered. The binding can fight infection in several ways. Antibodies can bind to viruses or bacteria, which interferes with the chemical interactions required for them to infect or bind to other cells. The antibodies may create bridges between different particles containing antigenic sites, clumping them all together and preventing their proper functioning. Antibody neutralization can prevent pathogens from entering and infecting host cells. The neutralized antibody-coated pathogens can then be filtered by the spleen to be eliminated in urine or feces. The antigen-antibody complex stimulates the complement system described previously, destroying the cell bearing the antigen. Antibodies also opsonize pathogen cells, wherein they mark them for destruction by phagocytic cells, such as macrophages or neutrophils. Additionally, antibodies stimulate inflammation, while their presence in mucus and on the skin prevents pathogen attack.
Methods by which antibodies inhibit infection: Antibodies may inhibit infection by (a) preventing the antigen from binding its target, (b) tagging a pathogen for destruction by macrophages or neutrophils, or (c) activating the complement cascade.
The production of antibodies by plasma cells in response to an antigen is called active immunity. This describes the host’s active response of the immune system to an infection or to a vaccination. There is also a passive immune response wherein antibodies are introduced into the host from an outside source, instead of the individual’s own plasma cells. For example, antibodies circulating in a pregnant woman’s body move across the placenta into the developing fetus. The child benefits from the presence of these antibodies for up to several months after birth. In addition, a passive immune response is possible by injecting antibodies into an individual in the form of an antivenom to a snake-bite toxin or antibodies in blood serum to help fight a hepatitis infection, giving immediate relief.